Association of CYP2C9*2 with bosentan-induced liver injury.
Clinical Pharmacology And Therapeutics
Markova, S M SM; De Marco, T T; Bendjilali, N N; Kobashigawa, E A EA; Mefford, J J; Sodhi, J J; Le, H H; Zhang, C C; Halladay, J J; Rettie, A E AE; Khojasteh, C C; McGlothlin, D D; Wu, A H B AH; Hsueh, W-C WC; Witte, J S JS; Schwartz, J B JB; Kroetz, D L DL
The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications.
Antimicrobial Agents And Chemotherapy
Chigutsa, Emmanuel E; Visser, Marianne E ME; Swart, Elizabeth C EC; Denti, Paolo P; Pushpakom, Sudeep S; Egan, Deirdre D; Holford, Nicholas H G NH; Smith, Peter J PJ; Maartens, Gary G; Owen, Andrew A; McIlleron, Helen H